Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT01892371
Brief Title: Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

First Submitted : July 1, 2013
First Submitted that Met QC Criteria : July 1, 2013
First Posted : July 4, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : December 28, 2019
Last Update Posted : January 2, 2020